Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Marco Jansen"'
Autor:
Judith Wienke, Maaike Nederend, Jeanette Leusen, Marjolein Stip, Marco Jansen, Chilam Chan, Femke van den Ham, Geert van Tetering, Elsemieke Passchier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Approximately half of the neuroblastoma patients develop high-risk neuroblastoma. Current treatment involves a multimodal strategy, including immunotherapy with dinutuximab (IgG ch14.18) targeting GD2. Despite achieving promising results,
Externí odkaz:
https://doaj.org/article/b79a80b51faa484288067e852353cc9d
Autor:
Alexander Rosbak-Mortensen, Marco Jansen, Morten Muhlig, Mikkel Bjørndahl Kristensen Tøt, Ivan Nikolov
Publikováno v:
Computers, Vol 13, Iss 3, p 70 (2024)
Automatic anomaly detection plays a critical role in surveillance systems but requires datasets comprising large amounts of annotated data to train and evaluate models. Gathering and annotating these data is a labor-intensive task that can become cos
Externí odkaz:
https://doaj.org/article/ce444f48cfe944a4a26afa10223f6d0b
Autor:
Miranda P Dierselhuis, Maaike Nederend, Jeanette H W Leusen, Mitchell Evers, Marco Jansen, Chilam Chan, Thomas Valerius, Friederike Meyer-Wentrup, Annelisa M Cornel, Marjolein C Stip, Karli R Reiding, Mirjam J Damen, Albert J R Heck, Sofia Koustoulidou, Ruud Ramakers, Gerard C Krijger, Remmert de Roos, Edouard Souteyrand, Mark de Boer, Geert van Tetering
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background Immunotherapy targeting GD2 is very effective against high-risk neuroblastoma, though administration of anti-GD2 antibodies induces severe and dose-limiting neuropathic pain by binding GD2-expressing sensory neurons. Previously, the IgG1 c
Externí odkaz:
https://doaj.org/article/91ef00d451c44452a3b035076288a7e9
Autor:
Stefan Nierkens, Niels Eijkelkamp, Maaike Nederend, Jeanette Leusen, Mitchell Evers, Marjolein Stip, Kaylee Keller, Hanneke Willemen, Marco Jansen, Chilam Chan, Kevin Budding, Thomas Valerius, Friederike Meyer-Wentrup
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/22ca94048a6c4dd2acf901975662eb6e
Autor:
Saeid Tabein, Marco Jansen, Emanuela Noris, Anna Maria Vaira, Daniele Marian, S. Ali Akbar Behjatnia, Gian Paolo Accotto, Laura Miozzi
Publikováno v:
Frontiers in Plant Science, Vol 11 (2020)
Tomato spotted wilt virus (TSWV) is a devastating plant pathogen, causing huge crop losses worldwide. Unfortunately, due to its wide host range and emergence of resistance breaking strains, its management is challenging. Up to now, resistance to TSWV
Externí odkaz:
https://doaj.org/article/1a2b70b9bf754d7d85302ed6943a8fe0
Autor:
Leusen, Chilam Chan, Marta Lustig, J. H. Marco Jansen, Laura Garcia Villagrasa, Leon Raymakers, Lois A. Daamen, Thomas Valerius, Geert van Tetering, Jeanette H. W.
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3405
Immunotherapy with targeted therapeutic antibodies is often ineffective in long-term responses in cancer patients due to resistance mechanisms such as overexpression of checkpoint molecules. Similar to T lymphocytes, myeloid immune cells express inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::57b0a14e736be5df4837b4b581db3bce
Autor:
Arianne M. Brandsma, Sina Bondza, Mitchell Evers, Rosanne Koutstaal, Maaike Nederend, J. H. Marco Jansen, Thies Rösner, Thomas Valerius, Jeanette H. W. Leusen, Toine ten Broeke
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Antibody therapy of cancer is increasingly used in the clinic and has improved patient's life expectancy. Except for immune checkpoint inhibition, the mode of action of many antibodies is to recognize overexpressed or specific tumor antigens and init
Externí odkaz:
https://doaj.org/article/b6838f2bcf2f43ea938445174a3565ae
Autor:
Hanke L. Matlung, Jeanette H.W. Leusen, Thomas Valerius, Timo K. van den Berg, Taco W. Kuijpers, Katka Franke, Jan M. Prins, Paul J.J.H. Verkuijlen, Karin Schornagel, Steffen Kahle, Michel van Houdt, J.H. Marco Jansen, Thies Rösner, Toine ten Broeke, Louise W. Treffers
Therapeutic monoclonal antibodies (mAb), directed toward either tumor antigens or inhibitory checkpoints on immune cells, are effective in cancer therapy. Increasing evidence suggests that the therapeutic efficacy of these tumor antigen–targeting m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed4d0b16a582b60db76330392fc3c53
https://doi.org/10.1158/2326-6066.c.6550411.v1
https://doi.org/10.1158/2326-6066.c.6550411.v1
Autor:
Hanke L. Matlung, Jeanette H.W. Leusen, Thomas Valerius, Timo K. van den Berg, Taco W. Kuijpers, Katka Franke, Jan M. Prins, Paul J.J.H. Verkuijlen, Karin Schornagel, Steffen Kahle, Michel van Houdt, J.H. Marco Jansen, Thies Rösner, Toine ten Broeke, Louise W. Treffers
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5df862a7afcfbe329059688740137f9
https://doi.org/10.1158/2326-6066.22543807
https://doi.org/10.1158/2326-6066.22543807
Autor:
Hanke L. Matlung, Jeanette H.W. Leusen, Thomas Valerius, Timo K. van den Berg, Taco W. Kuijpers, Katka Franke, Jan M. Prins, Paul J.J.H. Verkuijlen, Karin Schornagel, Steffen Kahle, Michel van Houdt, J.H. Marco Jansen, Thies Rösner, Toine ten Broeke, Louise W. Treffers
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9b8f6a57e4ee63d57d35612a94a925
https://doi.org/10.1158/2326-6066.22543804.v1
https://doi.org/10.1158/2326-6066.22543804.v1